Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

Details for Australian Patent Application No. 2001276218 (hide)

Owner Oncolytics Biotech Inc.

Inventors Thompson, Bradley, G.; Coffey, Matthew, C.; Thompson, Bradley G.; Coffey, Matthew C.

Agent Cullen & Co

Pub. Number AU-B-2001276218

PCT Pub. Number WO02/11742

Priority 09636597 10.08.00 US

Filing date 20 July 2001

Wipo publication date 18 February 2002

Acceptance publication date 3 August 2006

International Classifications

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/13 (2006.01) Medicinal preparations containing peptides

Event Publications

19 June 2003 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 21 Jan 2003

21 April 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Oncolytics Biotech, Inc. to Oncolytics Biotech Inc.

3 August 2006 Application Accepted

  Published as AU-B-2001276218

24 August 2006 Corrigenda

  Applications Accepted - Name Index Under the name Oncolytics Biotech Inc., Application No. 2001276218, under INID (72), amend the co-inventors to Thompson, Bradley G. and Coffey, Matthew C.

30 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001276219

2001276217